GlassScriptPhysician profile
John W Josephson
NPI 1154588374
$23,729.69
in general payments reported to CMS, 2019-2025
23 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $57.35 · 2021: $399 · 2022: $1,126 · 2023: $2,765 · 2024: $4,584 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $3,490 · Food and Beverage: $2,716 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,400 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,025.00 |
| Travel and Lodging | $3,489.76 |
| Food and Beverage | $2,715.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,400.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $14,289.21 | 2022-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Carl Zeiss Meditec USA, INC. | $3,641.87 | 2023-2024 | Iolmaster 700, Veracity Surgical, Visumax |
| Ziemer USA | $1,400.00 | 2024 | Femtoldv |
| Alcon Vision LLC | $1,310.52 | 2019-2025 | Clareon, Wavelight Sightmap, Luxor |
| Rxsight INC | $1,225.99 | 2022-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| New World Medical,INC. | $497.22 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $338.89 | 2024 | Xdemvy |
| Glaukos Corporation | $291.20 | 2022-2025 | Photrexa, Photrexa Viscous and Photrexa, Kxl1b-Ce-Marked Kxlsystem |
| Merz North America, INC. | $159.72 | 2019 | |
| Dompe US, INC. | $128.35 | 2019-2024 | Oxervate |
| Biotissue Holdings INC. | $113.28 | 2019-2025 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $43.37 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.23 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $36.72 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $27.18 | 2025 | Vevye |
| Abbvie INC. | $19.68 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $17.37 | 2022 | |
| Lensar, INC. | $15.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.41 | 2020 | |
| Oyster Point Pharma, INC. | $15.36 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Josephson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.